HomeFileCoronary disease

Coronary disease

Vasculitis, Thrombosis and Angiogenesis: Covid-19´s Unique Patters

In this small, yet interesting series, we observe angiogenesis could differentiate pulmonary physiopathology by Covid-19 vs. from...

Differences in Plaque Progression Depending on its Characteristics

The pattern of growth for each plaque differs according to the presence of certain risk factors. Atheroma...

Subintimal Re-Entry in CTO Improves Outcomes

Courtesy of Dr. Carlos Fava. Chronic total occlusions (CTO) are still one of the greatest challenges in our field,...

European Association of Percutaneous Cardiovascular Interventions Position Statement During the Pandemic

This document emerges from the assembly of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) and the...

EuroPCR 2020 | A Trick to Find the Perfect Projection to Treat Ostia or Bifurcation Lesions

The trick is to avoid testing empirically more to the right or to the left, a more...

IVUS in Unprotected LMCA Angioplasty: Should We Change the Way We Use It?

Courtesy of Dr. Carlos Fava. Bifurcation lesions account for about 25% of all angioplasties and it is a challenge...

EuroPCR 2020 | FABOLUS FASTER: In the Quest for the Fastest, Most Potent Platelet Inhibition

This small study tested the pharmacodynamic effects of several antiplatelet agents. It concluded that tirofiban (Aggrastat) provides...

EuroPCR 2020 | Deferral Based on iFR vs. FFR: Are They Equivalent or Is There a New “Gold Standard”?

Age may impact results when making an angioplasty choice based on fractional flow reserve (FFR) vs. instantaneous...